These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

170 related articles for article (PubMed ID: 17027071)

  • 21. Analysis of both NM23-h1 and NM23-H2 expression identifies "at-risk" patients with colorectal cancer.
    Brenner AS; Thebo JS; Senagore AJ; Duepree HJ; Gramlich T; Ormsby A; Lavery IC; Fazio VW
    Am Surg; 2003 Mar; 69(3):203-8; discussion 208. PubMed ID: 12678475
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Expression of nm23-H1 in uveal melanoma.
    Bakalian S; Marshall JC; Faingold D; Logan P; Antecka E; Burnier MN
    Melanoma Res; 2007 Oct; 17(5):284-90. PubMed ID: 17885583
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Expressions of proliferation markers (Ki-67, proliferating cell nuclear antigen, and silver-staining nucleolar organizer regions) and of p53 tumor protein in gestational trophoblastic disease.
    Kale A; Söylemez F; Ensari A
    Am J Obstet Gynecol; 2001 Mar; 184(4):567-74. PubMed ID: 11262454
    [TBL] [Abstract][Full Text] [Related]  

  • 24. CD44v6 and Nm23-H1 protein expression related to clinico pathological parameters in colorectal cancer.
    Messinetti S; Giacomelli L; Fabrizio G; Giarnieri E; Gabatel R; Manno A; Feroci D; Guerriero G; Masci E; Vecchione A
    Ann Ital Chir; 2003; 74(1):45-51. PubMed ID: 12870281
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Comparative proteomic analysis between benign and malignant-transformed hydatidiform mole.
    Ma L; Xiang Y; Zhao J; Feng F; Wan X
    J Reprod Med; 2008 Aug; 53(8):623-8. PubMed ID: 18773628
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Expression of nm23 protein in adult soft tissue sarcoma is correlated with histological grade.
    D'Souza RJ; Sheikh ZA; Busund LT; Russell PJ; Crowe PJ; Yang JL
    Anticancer Res; 2003; 23(4):3289-94. PubMed ID: 12926065
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Telomerase activity in complete hydatidiform mole.
    Sukcharoen N; Mutirangura A; Limpongsanurak S
    J Reprod Med; 1999 May; 44(5):465-70. PubMed ID: 10360262
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Assessment of Her-2/neu expression in hydatidiform moles for prediction of subsequent gestational trophoblastic neoplasia.
    Menczer J; Schreiber L; Berger E; Golan A; Levy T
    Gynecol Oncol; 2007 Mar; 104(3):675-9. PubMed ID: 17126893
    [TBL] [Abstract][Full Text] [Related]  

  • 29. A model for the behavior of beta-hCG after evacuation of hydatidiform moles.
    Schoeberl MR
    Gynecol Oncol; 2007 Jun; 105(3):776-9. PubMed ID: 17395254
    [TBL] [Abstract][Full Text] [Related]  

  • 30. C-erbB-2 amplification and expression in gestational trophoblastic disease correlates with DNA content and karyotype.
    Bauer M; Horn LC; Kowalzik J; Mair W; Czerwenka K
    Gen Diagn Pathol; 1997 Nov; 143(2-3):185-90. PubMed ID: 9443575
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Expression of metastasis associated proteins, CD44v6 and NM23-H1, in pediatric acute lymphoblastic leukemia.
    Magyarosy E; Sebestyén A; Timár J
    Anticancer Res; 2001; 21(1B):819-23. PubMed ID: 11299850
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Clinical significance of nm23 gene expression in gastric cancer.
    Mönig SP; Nolden B; Lübke T; Pohl A; Grass G; Schneider PM; Dienes HP; Hölscher AH; Baldus SE
    Anticancer Res; 2007; 27(4C):3029-33. PubMed ID: 17695492
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The risk of persistent trophoblastic disease after hydatidiform mole classified by morphology and ploidy.
    Niemann I; Hansen ES; Sunde L
    Gynecol Oncol; 2007 Feb; 104(2):411-5. PubMed ID: 17011616
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Inhibin/activin subunits are immunohistochemically expressed in complete and partial hydatidiform moles.
    Mylonas I; Shabani N; Vogl J; Makovitzky J; Kunze S; Kuhn C; Schulze S; Friese K; Jeschke U
    Anticancer Res; 2007; 27(4A):1995-2000. PubMed ID: 17649811
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Alteration in gene expression profile and biological behavior in human lung cancer cell line NL9980 by nm23-H1 gene silencing.
    Ma W; Chen J; Xue X; Wang Z; Liu H; Wang T; Bai Y; Tang SC; Zhou Q
    Biochem Biophys Res Commun; 2008 Jul; 371(3):425-30. PubMed ID: 18440302
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Expression and significance of LMP2 and PPM1A in gestational trophoblastic disease].
    Zhang SS; Wan XY; Zhou CY; Lü WG; Xie X
    Zhonghua Fu Chan Ke Za Zhi; 2011 Jul; 46(7):510-5. PubMed ID: 22041443
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Immunohistochemical staining for diagnosis and prognostic assessment of hydatidiform moles: current evidence and future directions.
    Sebire NJ; Seckl MJ
    J Reprod Med; 2010; 55(5-6):236-46. PubMed ID: 20626180
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Recurrent gestational trophoblastic disease after hCG normalization following hydatidiform mole in The Netherlands.
    Kerkmeijer LG; Wielsma S; Massuger LF; Sweep FC; Thomas CM
    Gynecol Oncol; 2007 Jul; 106(1):142-6. PubMed ID: 17462723
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Mutation and expression of nm23-H1 and CD44 gene in prostate cancers].
    Wan H; Wu M; Yu S; Qiang W; Liu T
    Zhonghua Wai Ke Za Zhi; 2000 May; 38(5):382-4. PubMed ID: 11832065
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Indoleamine 2,3-dioxygenase expression in gestational trophoblastic disease: implications for development of immunotherapeutic approaches.
    Sebire NJ; Fisher RA; Williams S; Prendergast G; Savage P; Seckl M
    J Reprod Med; 2008 Oct; 53(10):789-92. PubMed ID: 19004406
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.